Loading...

Cell-Vive™ GMP Recombinant Human IL-33 (carrier-free)

Pricing & Availability
Other Names
C9orf26, IL1F11, NFHEV, DVS 27
Ave. Rating
Submit a Review
Product Citations
publications
Human_IL-33_CF_GMP-RECOM_1_112421
GMP recombinant human IL-33 induces dose-dependent proliferation of D10.G4.1 cells. Deep Blue Cell Viability™ Kit (Cat. No. 424701) is used to measure the proliferation. The ED50 range for this effect is 0.1 - 0.5 ng/mL.
  • Human_IL-33_CF_GMP-RECOM_1_112421
    GMP recombinant human IL-33 induces dose-dependent proliferation of D10.G4.1 cells. Deep Blue Cell Viability™ Kit (Cat. No. 424701) is used to measure the proliferation. The ED50 range for this effect is 0.1 - 0.5 ng/mL.
Cat # Size Price Quantity Check Availability Save
581816 100 µg 1202 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
581814 25 µg 440 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote

Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.

Description

IL-33 belongs to the IL-1 family and is closely related in structure to IL-18 and IL-1β. IL-33, IL-1β, and IL-18 are synthesized as biologically inactive precursors and are cleaved by the enzyme caspase-1 to be secreted as active mature forms. IL-33 stimulates target cells by binding to the IL-1R/TLR superfamily member ST2 and, subsequently, activates NF-κβ and MAPK pathways via identical signalling events to those observed for IL-1β. In addition, IL-33 is a nuclear factor (NF-HEV) abundantly expressed in high endothelial venules from lymphoid organs that associate with chromatin and exhibit transcriptional regulatory properties.

Product Details
Quality Statement

BioLegend Cell-Vive™ GMP Recombinant proteins are manufactured and tested in accordance with USP Chapter 1043, Ancillary Materials for Cell, Gene and Tissue-Engineered Products and Ph. Eur. Chapter 5.2.12 in a dedicated GMP facility compliant with ISO 13485:2016. Specifications and processes include:

  • Low endotoxin level (≤ 0.1 EU/μg)
  • Purity (≥ 95% or higher)
  • Bioburden testing
  • Mycoplasma testing
  • Batch-to-batch consistency
  • Vendor qualification
  • Raw material traceability and documentation
  • Documented procedures and employee training
  • Equipment maintenance and monitoring records
  • Lot-specific certificates of analysis
  • Quality audits per ISO 13485:2016
  • QA review of released products
Technical Data Sheet (pdf)

Product Details

Source
Human IL-33, amino acids Ser112-Thr270 (Accession# NM_ 033439) was expressed in E. coli.
Molecular Mass
The 159 amino acid recombinant protein has a predicted molecular mass of approximately 18 kD. The DTT-reduced protein migrates at approximately 19 kD and non-reduced protein migrates at approximately 20 kD by SDS-PAGE. The N-terminal amino acid is Serine.
N-terminal
Sequence Analysis
Ser-Ile-Thr-Gly-Ile-Ser-Pro-Ile-Thr-Glu
Purity
≥ 95%, as determined by Coomassie stained SDS-PAGE
Formulation
0.1 µm filtered protein solution is in PBS, 1 mM EDTA, 2 mM TCEP
Endotoxin Level
Less than or equal to 0.1 EU per μg protein as determined by the LAL method
Residual Host Cell Protein Content
≤ 0.500 ng/μg by ELISA
Concentration
500 µg/mL
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% endotoxin-free BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week or stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
ED50 = 0.1 - 0.5 ng/mL as determined by the dose-dependent stimulation of D10.G4.1 cell proliferation. Deep Blue Cell Viability™ Kit (Cat. No. 424701) is used to measure the proliferation.
Application

Bioassay
Cell Culture
Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Disclaimer

BioLegend Cell-Vive™ GMP Recombinant proteins are for research use only. Suitable for ex vivo cell processing. Not for injection or diagnostic or therapeutic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

Antigen Details

Structure
Cytokine
Distribution

IL-33 mRNA is expressed in a broad range of human tissues, such as heart, small intestine, brain, ovary, testis, pancreas, and colon. Higher IL-33 expression was detected in human keratinocyte, fibroblast, myocyte, and alveolar cells

Function
IL-33 drives production of Th2-associated cytokines from in vitro polarized Th2 cells. In mice, IL-33 injection induced the expression of IL-4, IL-5, and IL-13 and led to severe pathological changes in the lung and the digestive tract. In addition, IL-33 acts as a chemoattractant for Th2 cells, both in vitro and in vivo. TNF-α and IL-1β are activators of IL-33 transcription in fibroblasts and keratinocytes.
Interaction
Th2 cells, mast cells, basophils, eosinophils and natural killer cells
Ligand/Receptor
IL-1 family receptor T1/ST2 and IL-1RAcP (IL-1 receptor associated protein).
Bioactivity
Measured by its ability to induce proliferation of D10.G4.1 cells.
Biology Area
Cell Biology, Immunology, Stem Cells, Transcription Factors
Molecular Family
Cytokines/Chemokines
Antigen References
  1. Schmitz J, et al. 2005. Immunity. 23:479-90.
  2. Barksby HE, et al. 2007. Clin Exp Immunol. 149:217-25.
  3. Arend WP, et al. 2008. Immunol Rev. 223:20-38.
  4. Suzukawa M, et al. 2008. J Immunol. 181:5981-9.
  5. Moussion C, et al. 2008. PLoS One. 3:e3331.
  6. Mildner M, et al. 2010. Cardiovasc Res. 87:769-77.
Gene ID
90865 View all products for this Gene ID
UniProt
View information about IL-33 on UniProt.org
Go To Top Version: 2    Revision Date: 08.22.2024

For Research Use Only. Suitable for ex vivo cell processing. Not for injection or diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account